US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist

5.2400
-0.0500-0.95%

Close May 1 16:00 ET

5.2800
+0.0400+0.76%

Post 19:43 ET

3.98MMarket Cap-19P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 12, 2022

(Q4)Dec 12, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.39K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

-315.52K

-373.95K

Net income from continuing operations

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

---2M

---3.75M

Operating gains losses

----

237.46%607K

1,627.88%186.4K

149.59%228.1K

---19.6K

--212.1K

Depreciation and amortization

5.39%10.4K

25.73%2.6K

0.00%2.6K

-5.12%9.87K

-20.46%2.07K

0.00%2.6K

--2.6K

Deferred tax

---9.48M

---596.07K

---485

---7.84M

---1.05M

--0

Other non cash items

1,507.01%1.92M

12.19%89.66K

159.33%22.82K

6,983.50%1.78M

-58.22%22.05K

-62.43%119.41K

21.28%79.92K

-144.27%-38.46K

--25.19K

--52.76K

Change In working capital

-68.64%2.6M

-139.72%-1.4M

-35.13%1.7M

165.40%2.61M

-126.65%-310.56K

912.68%8.29M

642.30%3.52M

1,604.21%2.62M

--984.56K

--1.17M

-Change in prepaid assets

-41.37%193.07K

-50.33%112.58K

-49.82%460.39K

170.65%321.1K

-94.53%-701K

210.84%329.3K

840.05%226.67K

2,821.28%917.49K

---454.49K

---360.36K

-Change in payables and accrued expense

-68.85%2.51M

-143.94%-1.49M

-23.71%1.26M

58.50%2.32M

-73.21%414.69K

1,212.90%8.05M

569.51%3.38M

1,254.84%1.66M

--1.46M

--1.55M

-Change in other current liabilities

-16.26%-100.1K

70.16%-25.69K

-156.64%-25.28K

-10.10%-24.88K

-10.09%-24.25K

---86.1K

--44.63K

---22.6K

---22.03K

Cash from discontinued investing activities

Operating cash flow

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

---315.52K

---373.95K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

512.88K

662.8K

296.4K

393.3K

Net common stock issuance

--18.11M

--5M

--2.1M

----

--0

----

Net preferred stock issuance

-644.44%-10.7M

-100.00%-1

-123.08%-230K

-1,046,561,100.00%-10.47M

--0

--1.96M

--548.8K

--996.4K

--1

--419.32K

Proceeds from stock option exercised by employees

--967.48K

--179

3,638.79%972.8K

----

--0

--26.02K

----

Net other financing activities

-2,343.61%-2.42M

-1,719.30%-653.51K

-54.45%-555.43K

-465.67%-1.18M

-33.26%-34.67K

---99.14K

---35.92K

---359.62K

--322.42K

---26.02K

Cash from discontinued financing activities

Financing cash flow

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

--512.88K

--662.8K

--296.4K

--393.3K

Net cash flow

Beginning cash position

1,696.27%5.9M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

1,696.27%5.9M

88.12%328.58K

-36.20%602.75K

-79.99%328.82K

--347.93K

--328.58K

Current changes in cash

-845.67%-2.76M

1,514.27%1.56M

392.83%1.35M

-5,389.54%-1.05M

-23,997.29%-4.62M

140.88%370.74K

115.67%96.57K

139.23%273.94K

---19.12K

--19.35K

End cash Position

348.67%3.14M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

112.83%699.32K

-36.20%602.75K

--328.82K

--347.93K

Free cash flow

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

---315.52K

---373.95K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 12, 2022	(Q4)Dec 12, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.39K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	-315.52K	-373.95K
Net income from continuing operations	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	---2M	---3.75M
Operating gains losses	----	----	----	----	----	237.46%607K	1,627.88%186.4K	149.59%228.1K	---19.6K	--212.1K
Depreciation and amortization	5.39%10.4K	25.73%2.6K	0.00%2.6K	0.00%2.6K	0.00%2.6K	-5.12%9.87K	-20.46%2.07K	0.00%2.6K	--2.6K	--2.6K
Deferred tax	---9.48M	---596.07K	---485	---7.84M	---1.05M	--0	--0	--0	--0	--0
Other non cash items	1,507.01%1.92M	12.19%89.66K	159.33%22.82K	6,983.50%1.78M	-58.22%22.05K	-62.43%119.41K	21.28%79.92K	-144.27%-38.46K	--25.19K	--52.76K
Change In working capital	-68.64%2.6M	-139.72%-1.4M	-35.13%1.7M	165.40%2.61M	-126.65%-310.56K	912.68%8.29M	642.30%3.52M	1,604.21%2.62M	--984.56K	--1.17M
-Change in prepaid assets	-41.37%193.07K	-50.33%112.58K	-49.82%460.39K	170.65%321.1K	-94.53%-701K	210.84%329.3K	840.05%226.67K	2,821.28%917.49K	---454.49K	---360.36K
-Change in payables and accrued expense	-68.85%2.51M	-143.94%-1.49M	-23.71%1.26M	58.50%2.32M	-73.21%414.69K	1,212.90%8.05M	569.51%3.38M	1,254.84%1.66M	--1.46M	--1.55M
-Change in other current liabilities	-16.26%-100.1K	70.16%-25.69K	-156.64%-25.28K	-10.10%-24.88K	-10.09%-24.25K	---86.1K	---86.1K	--44.63K	---22.6K	---22.03K
Cash from discontinued investing activities
Operating cash flow	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	---315.52K	---373.95K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	512.88K	662.8K	296.4K	393.3K
Net common stock issuance	--18.11M	--5M	--2.1M	----	----	--0	--0	--0	----	----
Net preferred stock issuance	-644.44%-10.7M	-100.00%-1	-123.08%-230K	-1,046,561,100.00%-10.47M	--0	--1.96M	--548.8K	--996.4K	--1	--419.32K
Proceeds from stock option exercised by employees	--967.48K	--179	3,638.79%972.8K	----	----	--0	--0	--26.02K	----	----
Net other financing activities	-2,343.61%-2.42M	-1,719.30%-653.51K	-54.45%-555.43K	-465.67%-1.18M	-33.26%-34.67K	---99.14K	---35.92K	---359.62K	--322.42K	---26.02K
Cash from discontinued financing activities
Financing cash flow	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	--512.88K	--662.8K	--296.4K	--393.3K
Net cash flow
Beginning cash position	1,696.27%5.9M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	1,696.27%5.9M	88.12%328.58K	-36.20%602.75K	-79.99%328.82K	--347.93K	--328.58K
Current changes in cash	-845.67%-2.76M	1,514.27%1.56M	392.83%1.35M	-5,389.54%-1.05M	-23,997.29%-4.62M	140.88%370.74K	115.67%96.57K	139.23%273.94K	---19.12K	--19.35K
End cash Position	348.67%3.14M	348.67%3.14M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	112.83%699.32K	112.83%699.32K	-36.20%602.75K	--328.82K	--347.93K
Free cash flow	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	---315.52K	---373.95K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall